摘要
目的观察和探析地奥心血康和尼莫地平在治疗偏头痛患者的临床治疗效果。方法选取该院2012年6月—2014年5月收治的偏头痛患者共265例,按照随机的原则,将其分成观察组130例和对照组各135例,对照组给予尼莫西平进行治疗,对于观察组患者,则在对照组治疗的基础上,另外加用地奥心血康,每3个月为一疗程。然后对比两组患者的治愈率和总有效率。结果经过60 d治疗,观察组患者的治愈率和总有效率分别为82.3%和95.4%,明显高于对照组患者,两组患者的治愈率和总有效率对比,差异有统计学意义(P<0.05),两组患者均没有发生不良反应。结论对于偏头痛患者,地奥心血康和尼莫地平联合使用,有着安全有效和副作用少的优点,非常值得在临床推广和应用。
Objective To observe and analyze the clinical effect of Di＇ao Xinxuekang and Nimodipine in the treatment of patients with migraine. Methods 265 cases with migraine admitted in our hospital from June 2013 to May 2014 were selected and randomly divided into the observation group（130 cases） and the control group（135 cases）. The control group were treated by Nimodipine,and the observation group were treated by Di＇ao Xinxuekang based on the treatment given to the control group. 3 months was a course of treatment. And the cure rate and total effective rate of two groups of patients were compared. Results After 60 days of treatment, the cure rate and total effective rate of the observation group was 82.3% and 95.4%, respectively, obviously higher than that of the control group, respectively, with statistically significant difference（P 0.05）. No adverse reactions occurred in both groups. Conclusion For patients with migraine, Di＇ao Xinxuekang combined with Nimodipine are more safe and effective with less side effects, so it is worthy of clinical promotion and application.
出处
《中外医疗》
2014年第35期20-21,共2页
China & Foreign Medical Treatment
